High-throughput method for the analysis of venlafaxine in pharmaceutical formulations and biological fluids, using a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate chemiluminescence system in a two-chip device

Haider A.J. Al Lawati*, Gouri B. Varma, Fakhr Eldin O. Suliman

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمقالمراجعة النظراء

11 اقتباسات (Scopus)

ملخص

A simple, rapid and sensitive chemiluminescent (CL) method for the assay of venlafaxine (VEN) in pharmaceutical formulations and serum samples by a two-chip device is proposed. The method is based on the reaction of this drug with a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate CL system. The optimum chemical conditions for CL emission were investigated. The calibration graph was linear for the concentration range 0.02-8.0 μg/mL. The detection and quantification limits were found to be 0.006 and 0.018 μg/mL, respectively, while the relative standard deviation (RSD) was <2.0%. The present CL procedure was applied to the determination of VEN in pharmaceutical formulations and serum samples; the recovery levels were in the range 96.5-101.2%. The results suggest that the method is unaffected by the presence of common formulation excipients found in these samples.

اللغة الأصليةEnglish
الصفحات (من إلى)44-49
عدد الصفحات6
دوريةLuminescence
مستوى الصوت28
رقم الإصدار1
المعرِّفات الرقمية للأشياء
حالة النشرPublished - 2013

ASJC Scopus subject areas

  • ???subjectarea.asjc.1300.1304???
  • ???subjectarea.asjc.1600.1601???

بصمة

أدرس بدقة موضوعات البحث “High-throughput method for the analysis of venlafaxine in pharmaceutical formulations and biological fluids, using a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate chemiluminescence system in a two-chip device'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا